Hairtamin LLC – Trademark Portfolio
Entity Type: 16
Hairtamin LLC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 7 trademarks are registered and 3 are pending. Notable registered marks include BLOATAMIN, HAIRTAMIN, SKINTAMIN, THINTAMIN, and IMMUNETAMIN. The owner is based in IRVINE, CA.
SUITE 150
18071 FITCH
IRVINE, CA 92614
Showing of trademarks Trademarks
Trademark Classifications
Hairtamin LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Hairtamin LLC have?
Hairtamin LLC has 13 U.S. trademarks filed with the USPTO. Of these, 7 registered, 3 pending, 2 abandoned, 1 cancelled.
What trademark classes does Hairtamin LLC file in?
Hairtamin LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Hairtamin LLC's most well-known trademarks?
Hairtamin LLC's registered trademark portfolio includes well-known marks such as BLOATAMIN, HAIRTAMIN, SKINTAMIN, THINTAMIN, and IMMUNETAMIN. These are among 7 currently registered trademarks in the portfolio.
What is Hairtamin LLC's trademark registration success rate?
Hairtamin LLC has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 3 applications are pending review.